James F. Tessmer, VP, Finance & Accounting at LEXICON PHARMACEUTICALS, INC. (LXRX), sold 10,000 shares at $12.91 ($129K) on 2018-06-08, disclosed to the SEC on 2018-06-12.
Open-market sale of $129k LXRX by VP, Finance & Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LXRX | SELL | 2016-06-08 | $23K | — | Filing → |
| LXRX | SELL | 2016-05-23 | $78K | — | Filing → |